Antibody and use thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7342105
APP PUB NO 20060177449A1
SERIAL NO

10547051

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The antibody of the present invention, which specifically reacts with the N-terminal or C-terminal partial peptide of TGR23-2 ligand, is useful in detecting and quantifying the TGR23-2 ligand. Moreover, it is useful as a preventing/treating agent and a diagnostic agent for cancer, etc.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TAKEDA PHARMACEUTICAL COMPANY LIMITED1-1 DOSHOMACHI 4-CHOME CHUO-KU OSAKA-SHI OSAKA 541-0045 JAPAN

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hashimoto, Eri Ibaraki, JP 4 12
Kitada, Chieko Osaka, JP 58 813
Matsumoto, Hirokazu Ibaraki, JP 65 211
Mori, Masaaki Ibaraki, JP 102 800

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation